Joel Embiid fights Bell's palsy to drop NBA playoff career high as ...

11 days ago
Bell's palsy

Philadelphia 76ers All-Star centre Joel Embiid has been diagnosed with Bell's palsy, a form of facial paralysis he says has affected him since before the play-in tournament.

Embiid wore sunglasses to the podium after he scored 50 points in the Sixers' Game 3 win over the New York Knicks and said he's battled various symptoms such as blurred vision and dry eyes.

Embiid said he first started suffering from the affliction about a "day or two" before the Sixers played the Miami Heat on April 17 in the play-in tournament. Embiid had 23 points and 15 rebounds in the win that sent the Sixers to the playoffs.

Embiid complained of migraines but "thought it was nothing" before he finally notified doctors he wasn't feeling well.

"My body was just, I was just not feeling it," he said.

"Yes, it's pretty annoying. My left side of my face, my mouth and my eye. It's been tough. But I'm not a quitter. I'm going to keep fighting through anything. It's unfortunate, that's the way I look at it. But it's not an excuse. I've got to keep pushing."

Last season's NBA MVP, Embiid was 13-of-19 from the floor, made 19 of 21 free throws and hit five three-pointers in Game 3.

The Knicks lead the series 2-1 and Game 4 is Sunday in Philadelphia.

Embiid had been wearing sunglasses throughout the series and conducted a Game 2 post-game interview with his head down in front of his locker to hide his symptoms.

Embiid said he has no timetable on how long it make take to recover from Bell's palsy.

"It hasn't really necessarily gotten better," he said.

"With the conversations that I've had, it could be weeks, it could be months. I just hope that it stays like this. I've got a beautiful face. I don't like when my mouth is looking the other way. Unfortunate situation but everything happens for a reason."

Sports content to make you think... or allow you not to. A newsletter delivered each Saturday.

AP

Posted 1 hours agoFri 26 Apr 2024 at 5:28am

Read more
Similar news
This week's most popular news